The Nevada State Athletic Commission leveled interim UFC Light Heayvweight Champion Jon Jones with a temporary suspension on Monday, and revealed the substances in which the 205-pounder tested positive for.
According to the NSAC, the June 16 test showed clomiphene, an anti-estrogenic substance, as well as small traces or letrozole, an aromatose that helpes prevent tesosterone from turning into estrogen. A potential hearing date regarding the violation could go down in September or October, according to the Nevada distrct attorney's office.
The 28-year old Jones tested positive after a June 16 out-of-competition test administered by the United States Anti Doping Agency (USADA). Jones was then pulled from his UFC 200 main event against Light Heavyweight Champion Daniel Cormier and replaced by Anderson Silva.
See Also: Conor McGregor Switching Up Training For Nate Diaz Re-Match, Coach Says
Former Jones opponents Rashad Evans and Chael Sonnen both stated publicly that estrogen blockers were the substances in question well before the news released.
Jones now faces a possible two year suspension under the terms of UFC's drug policy, in addition to any punishment from the NSAC. Jone's "B" sample also came back positive.
Jones stated in a press conference on July 8 that he is against PEDs, and
"I've been taking the same supplements the majority of my career. I've been so outspoken about being against any type of performance enhancers. To this day, I'm extremely against performance enhancers.The whole thing sucks. Being labeled as someone who would cheat hurts more than anything else I've ever been through in my career," said Jones.
By Sean Ross Sapp